available, this problem will grow. Importantly, failure to recommend a particular medication does not imply that it is contraindicated. Key evidence gaps include the comparative effectiveness and safety of different biologics, the optimal sequencing of treatments, and the role of NSAIDs. This update addressed only a subset of treatment questions. The 2015 recommendations that were not reexamined are to be considered extant. Recommendations are meant to describe the approach to treatment of the